Synopsis:
IL-6 plays a central role in the inflammatory process of several rheumatic diseases. IL-6 inhibitors have significantly impacted the treatment of these diseases, particularly rheumatoid arthritis and other inflammatory conditions, including large vessel vasculitis and adult onset Still disease. In this workshop, we would like to deepen our understanding of IL-6 inhibition therapy in these diseases and it’s future potential through presentations by four experts.
| Agenda - Thursday 4 September | |
|---|---|
|
|
Workshop chairpersons: Naoto Tamura and Yutaka Kawahito
|
|
0900-1030 |
Introduction
IL-6 inhibition in rheumatoid arthritis (including late onset RA) Shintaro Hirata IL-6 inhibition in Takayasu arteritis and giant cell arteritis Ramnath Misra IL-6 inhibition in adult onset Still disease Yuko Kaneko Future prospectives for IL-6 inhibition therapy Masayuki Nishide Closing |
